NYSE:HYH - Halyard Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$57.25 0.00 (0.00 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$57.25
Today's RangeN/A
52-Week Range$38.22 - $61.52
Average Volume438,537 shs
Market Capitalization$2.69 billion
P/E Ratio24.36
Dividend YieldN/A
Halyard Health logoHalyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Receive HYH News and Ratings via Email

Sign-up to receive the latest news and ratings for HYH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Surgical appliances & supplies


Debt-to-Equity Ratio0.43
Current Ratio3.22
Quick Ratio2.96


Trailing P/E Ratio24.36
Forward P/E Ratio32.71
P/E Growth3.68

Sales & Book Value

Annual Sales$611.60 million
Price / Sales4.40
Cash Flow$1.2427 per share
Price / Cash46.07
Book Value$25.95 per share
Price / Book2.21


EPS (Most Recent Fiscal Year)$2.35
Net Income$79.30 million
Net Margins7.72%
Return on Equity7.90%
Return on Assets4.38%


Outstanding Shares47,020,000
Market Cap$2,691.70

Halyard Health (NYSE:HYH) Frequently Asked Questions

What is Halyard Health's stock symbol?

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

How were Halyard Health's earnings last quarter?

Halyard Health (NYSE:HYH) issued its earnings results on Wednesday, May, 2nd. The medical instruments supplier reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.59. The medical instruments supplier had revenue of $156.40 million for the quarter, compared to analysts' expectations of $155.08 million. Halyard Health had a net margin of 7.72% and a return on equity of 7.90%. The business's revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the business earned $0.48 earnings per share. View Halyard Health's Earnings History.

What guidance has Halyard Health issued on next quarter's earnings?

Halyard Health updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.26.

What price target have analysts set for HYH?

5 Wall Street analysts have issued 1-year price objectives for Halyard Health's stock. Their predictions range from $50.00 to $67.00. On average, they anticipate Halyard Health's share price to reach $59.25 in the next year. This suggests a possible upside of 3.5% from the stock's current price. View Analyst Ratings for Halyard Health.

What is the consensus analysts' recommendation for Halyard Health?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halyard Health in the last year. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Halyard Health's key competitors?

Who are Halyard Health's key executives?

Halyard Health's management team includes the folowing people:
  • Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)
  • Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)
  • Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)
  • Mr. Joseph F. Woody, CEO & Director (Age 52)
  • Mr. Renato Negro, VP, Controller & Chief Accounting Officer

Has Halyard Health been receiving favorable news coverage?

News articles about HYH stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Halyard Health earned a media sentiment score of 0.12 on Accern's scale. They also assigned media headlines about the medical instruments supplier an impact score of 47.08 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Halyard Health's major shareholders?

Halyard Health's stock is owned by many different of retail and institutional investors. Top institutional investors include Channing Capital Management LLC (2.38%), Fox Run Management L.L.C. (0.03%) and McQueen Ball & Associates Inc. (0.01%). View Institutional Ownership Trends for Halyard Health.

Which institutional investors are selling Halyard Health stock?

HYH stock was sold by a variety of institutional investors in the last quarter, including Channing Capital Management LLC. View Insider Buying and Selling for Halyard Health.

Which institutional investors are buying Halyard Health stock?

HYH stock was bought by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C. and McQueen Ball & Associates Inc.. View Insider Buying and Selling for Halyard Health.

How do I buy shares of Halyard Health?

Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Halyard Health's stock price today?

One share of HYH stock can currently be purchased for approximately $57.25.

How big of a company is Halyard Health?

Halyard Health has a market capitalization of $2.69 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe.

How can I contact Halyard Health?

Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]

MarketBeat Community Rating for Halyard Health (NYSE HYH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  197 (Vote Outperform)
Underperform Votes:  208 (Vote Underperform)
Total Votes:  405
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.